An implantable bioartificial kidney may be ready for human trials by the end of the year, according to a recent update from the researchers.
If approved by the FDA, the breakthrough creation could save thousands of patients currently on the transplant list for a new kidney.
The Kidney Project, which is the coalition heading the contraption’s development, published an update today saying that they have been asked to conduct additional preclinical testing before receiving approval for human trials.
“While the request for additional evidence was not anticipated, it is a measure of the revolutionary nature of our project that there is no precedent for safety reviews of similar technology and materials,” wrote the organization. “In that light, it is understandable that the research ethics boards are requesting additional data to document the safety of the bioartificial kidney.”